Abstract
The efficacy of Ligularia fischeri (LF) for managing diabetic complications was evaluated by assessing inhibitory effects against advanced glycation end product (AGE) formation, rat lens aldose reductase (RLAR), and 1,1-diphenyl-2-picryl hydrazyl (DPPH) radical scavenging. The ethyl acetate fraction from 70% ethanol extracts of LF showed the highest DPPH radical scavenging activity of 53.90% at a concentration of 3.3 μg/mL. The ethyl acetate fraction exhibited the most potent AGE formation inhibition of 73.57% at a concentration of 55 μg/mL and showed the most potent RLAR inhibition of 88.97% at a concentration of 11.11 μg/mL. The ethyl acetate fraction exhibited the most potent antioxidant and anti-diabetic effects. Nuclear magnetic resonance via bioactivity-guided fractionation of the LF ethyl acetate fraction revealed that 3,4-dicaffeoylquinic acid was the bioactive compound. This compound from LF can be effective for prevention or treatment of diabetic complications.
Similar content being viewed by others
References
Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 15: 539–553 (1998)
Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura T, Nyengaard JR, van den Enden M, Kilo C, Tilton RG. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42: 801–813 (1993)
de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: A metaanalysis. Psychosom. Med. 63: 619–630 (2001)
Chung SS, Ho EC, Lam KS, Chung SK. Contribution of polyol pathway to diabetes-induced oxidative stress. J. Am. Soc. Nephrol. 14: S233–S236 (2003)
Reddy VP, Beyaz A. Inhibitors of the Maillard reaction and AGE breakers as therapeutics for multiple diseases. Drug Discov. Today 11: 646–654 (2006)
Park JY, Ha SW, King GL. The role of protein kinase C activation in the pathogenesis of diabetic vascular complications. Perit. Dial. Int. 19: S222–S227 (1999)
Buse MG. Hexosamines, insulin resistance, and the complications of diabetes: Current status. Am. J. Physiol. Endocrinol. Metab. 290: E1–E8 (2006)
Yabe-Nishimura C. Aldose reductase in glucose toxicity: A potential target for the prevention of diabetic complications. Pharmacol. Rev. 50: 21–33 (1998)
Dunlop M. Aldose reductase and the role of the polyol pathway in diabetic nephropathy. Kidney Int. Suppl. 58: S3–S12 (2000)
Brownlee M. The pathobiology of diabetic complications: A unifying mechanism. Diabetes 54: 1615–1625 (2005)
Costantino L, Rastelli G, Gamberini MC, Vinson JA, Bose P, Iannone A, Staffieri M, Antolini L, Del Corso A, Mura U, Albasini A. 1-Benzopyran-4-one antioxidants as aldose reductase inhibitors. J. Med. Chem. 42: 1881–1893 (1999)
Ahmed N. Advanced glycation endproducts-role in pathology of diabetic complications. Diabetes Res. Clin. Pract. 67: 3–21 (2005)
Brownlee M. Glycation products and the pathogenesis of diabetic complications. Diabetes Care 15: 1835–1843 (1992)
Wirasathien L, Pengsuparp T, Suttisri R, Ueda H, Moriyasu M, Kawanishi K. Inhibitors of aldose reductase and advanced glycation end products formation from the leaves of Stelechocarpus cauliflorus R.E. Fr. Phytomedicine 14: 546–550 (2007)
Maritim AC, Sanders RA, Watkins JB 3rd. Diabetes, oxidative stress, and antioxidants: A review. J. Biochem. Mol. Toxicol. 17: 24–38 (2003)
Choi J, Park JK, Lee KT, Park KK, Kim WB, Lee JH, Jung HJ, Park HJ. In vivo antihepatotoxic effects of Ligularia fischeri var. spiciformis and the identification of the active component, 3,4-dicaffeoylquinic acid. J. Med. Food 8: 348–352 (2005)
Lee KT, Koo SJ, Jung SH, Choi J, Jung HJ, Park HJ. Structure of three new terpenoids, spiciformisins a and b, and monocyclosqualene, isolated from the herbs of Ligularia fischeri var. spiciformis and cytotoxicity. Arch. Pharm. Res. 25: 820–823 (2002)
Zhang WJ, Li XH, Shi YP. A pair of epimeric spirosesquiterpenes from the roots of Ligularia fischeri. J. Nat. Prod. 73: 143–146 (2010)
Piao XL, Mi XY, Tian YZ, Wu Q, Piao HS, Zeng Z, Wang D, Piao X. Rapid identification and characterization of antioxidants from Ligularia fischeri. Arch. Pharm. Res. 32: 1689–1694 (2009)
Choi EM, Kim YH. A preliminary study of the effects of an extract of Ligularia fischeri leaves on type II collagen-induced arthritis in DBA/1J mice. Food Chem. Toxicol. 46: 375–379 (2008)
Lee BI, Nugroho A, Bachri MS, Choi J, Lee KR, Choi JS, Kim WB, Lee KT, Lee JD, Park HJ. Anti-ulcerogenic effect and HPLC analysis of the caffeoylquinic acid-rich extract from Ligularia stenocephala. Biol. Pharm. Bull. 33: 493–497 (2010)
Chon SU, Kim YM, Kim DK, Heo BG, Cho JY. Phytotoxic effect, DPPH radical scavenging activity and chlorogenic acid level of methanol extracts from aerial parts of several Korean salad plants. Koren J. Plant Res. 19: 405–410 (2006)
Jung HA, Jung YJ, Yoon NY, Jeong DM, Bae HJ, Kim DW, Na DH, Choi JS. Inhibitory effects of Nelumbo nucifera leaves on rat lens aldose reductase, advanced glycation endproducts formation, and oxidative stress. Food Chem. Toxicol. 46: 3818–3826 (2008)
Kim HS, Park UY, Seong YH. Inhibitory effects of ginseng components on rat lens aldose reductase activities. Korean J. Ginseng Sci. 20: 106–110 (1996)
Hayman S, Kinoshita JH. Isolation and properties of lens aldose reductase. J. Biol. Chem. 240: 877–882 (1965)
Choi EM, Ding Y, Nguyen HT, Park SH, Kim YH. Antioxidant activity of Gomchi (Ligularia fischeri) Leaves. Food Sci. Biotechnol. 16: 710–714 (2007)
Shang YF, Kim SM, Song DG, Pan CH, Lee WJ, Um BH. Isolation and identification of antioxidant compounds from Ligularia fischeri. J. Food Sci. 75: C530–C535 (2010)
Peyroux J, Sternberg M. Advanced glycation endproducts (AGEs): Pharmacological inhibition in diabetes. Pathol. Biol. (Paris) 54: 405–419 (2006)
Singh R, Barden A, Mori T, Beilin L. Advanced glycation end products: A review. Diabetologia 44: 129–146 (2001)
Lee HS, Hong CO, Lee KW. Advanced glycation endproduct-induced diabetic complications. Food Sci. Biotechnol. 17: 1131–1138 (2008)
Logendra S, Ribnicky DM, Yang H, Poulev A, Ma J, Kennelly EJ, Raskin I. Bioassay-guided isolation of aldose reductase inhibitors from Artemisia dracunculus. Phytochemistry 67: 1539–1546 (2006)
Arbiser JL, Li XC, Hossain CF, Nagle DG, Smith DM, Miller P, Govindarajan B, DiCarlo J, Landis-Piwowar KR, Dou QP. Naturally occurring proteasome inhibitors from mate tea (Ilex paraguayensis) serve as models for topical proteasome inhibitors. J. Invest. Dermatol. 125: 207–212 (2005)
Wu C, Chen F, Wang X, Wu Y, Dong M, He G, Galyean RD, He L, Huang G. Identification of antioxidant phenolic compounds in feverfew (Tanacetum parthenium) by HPLC-ESI-MS/MS and NMR. Phytochem. Anal. 18: 401–410 (2007)
Wan C, Yu Y, Zhou S, Tian S, Cao S. Isolation and identification of phenolic compounds from Gynura divaricata leaves. Pharmacogn. Mag. 7: 101–108 (2011)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yin, X.F., Jeon, Y.E., Shim, JH. et al. Inhibitory efficacy of Ligularia fischeri against aldose reductase and advanced glycation end products formation. Food Sci Biotechnol 23, 1747–1752 (2014). https://doi.org/10.1007/s10068-014-0239-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10068-014-0239-5